Literature DB >> 16553546

Potential role of high mobility group box 1 in viral infectious diseases.

Haichao Wang1, Mary F Ward, Xue-Gong Fan, Andrew E Sama, Wei Li.   

Abstract

A nuclear protein, high mobility group box 1 (HMGB1), is released passively by necrotic cells and actively by macrophages/monocytes in response to exogenous and endogenous inflammatory stimuli. After binding to the receptor for advanced glycation end products (RAGE), or Toll-like receptor 4 (TLR4), HMGB1 activates macrophages/monocytes to express proinflammatory cytokines, chemokines, and adhesion molecules. Pharmacological suppression of its activities or release is protective against lethal endotoxemia and sepsis, establishing HMGB1 as a critical mediator of lethal systemic inflammation. In light of observations that many viruses (e.g., West Nile virus, Salmon anemia virus) can induce passive HMGB1 release, we propose a potential pathogenic role of HMGB1 in viral infectious diseases.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16553546      PMCID： PMC1782047          DOI： 10.1089/vim.2006.19.3

Source DB:  PubMed          Journal:  Viral Immunol        ISSN： 0882-8245            Impact factor:   2.257


  62 in total

Review 1.  HMGB1 as a late mediator of lethal systemic inflammation.

Authors:  H Wang; H Yang; C J Czura; A E Sama; K J Tracey
Journal:  Am J Respir Crit Care Med       Date:  2001-11-15       Impact factor: 21.405

Review 2.  Immunopathogenesis of hepatitis C viral infection: Th1/Th2 responses and the role of cytokines.

Authors:  P M Jacobson Brown; M G Neuman
Journal:  Clin Biochem       Date:  2001-05       Impact factor: 3.281

3.  A new model of sciatic inflammatory neuritis (SIN): induction of unilateral and bilateral mechanical allodynia following acute unilateral peri-sciatic immune activation in rats.

Authors:  Marucia Chacur; Erin D Milligan; Lawrence S Gazda; Charles Armstrong; Haichao Wang; Kevin J Tracey; Steven F Maier; Linda R Watkins
Journal:  Pain       Date:  2001-12       Impact factor: 6.961

4.  The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway.

Authors:  Stefania Gardella; Cristina Andrei; Denise Ferrera; Lavinia V Lotti; Maria R Torrisi; Marco E Bianchi; Anna Rubartelli
Journal:  EMBO Rep       Date:  2002-09-13       Impact factor: 8.807

5.  HMGB-1, a DNA-binding protein with cytokine activity, induces brain TNF and IL-6 production, and mediates anorexia and taste aversion.

Authors:  Davide Agnello; Haichao Wang; Huan Yang; Kevin J Tracey; Pietro Ghezzi
Journal:  Cytokine       Date:  2002-05-21       Impact factor: 3.861

6.  Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation.

Authors:  Luis Ulloa; Mahendar Ochani; Huan Yang; Mahira Tanovic; Daniel Halperin; Runkuan Yang; Christopher J Czura; Mitchell P Fink; Kevin J Tracey
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-03       Impact factor: 11.205

7.  Release of chromatin protein HMGB1 by necrotic cells triggers inflammation.

Authors:  Paola Scaffidi; Tom Misteli; Marco E Bianchi
Journal:  Nature       Date:  2002-07-11       Impact factor: 49.962

8.  Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis.

Authors:  Henri J Huttunen; Carole Fages; Juha Kuja-Panula; Anne J Ridley; Heikki Rauvala
Journal:  Cancer Res       Date:  2002-08-15       Impact factor: 12.701

9.  Lethal H5N1 influenza viruses escape host anti-viral cytokine responses.

Authors:  Sang Heui Seo; Erich Hoffmann; Robert G Webster
Journal:  Nat Med       Date:  2002-08-26       Impact factor: 53.440

10.  HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice.

Authors:  Penny L Sappington; Runkuan Yang; Huan Yang; Kevin J Tracey; Russell L Delude; Mitchell P Fink
Journal:  Gastroenterology       Date:  2002-09       Impact factor: 22.682
View more
  32 in total

1.  PCV2 Induces Reactive Oxygen Species To Promote Nucleocytoplasmic Translocation of the Viral DNA Binding Protein HMGB1 To Enhance Its Replication.

Authors:  Renjie Sun; Siqi Sun; Yikai Zhang; Yingshan Zhou; Ying Shan; Xiaoliang Li; Weihuan Fang
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

2.  Hepatitis C virus infection is blocked by HMGB1 released from virus-infected cells.

Authors:  Jong Ha Jung; Ji Hoon Park; Min Hyeok Jee; Sun Ju Keum; Min-Sun Cho; Seung Kew Yoon; Sung Key Jang
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

3.  Lysosomal localization and mechanism of membrane penetration influence nonenveloped virus activation of the NLRP3 inflammasome.

Authors:  A U Barlan; P Danthi; C M Wiethoff
Journal:  Virology       Date:  2011-02-18       Impact factor: 3.616

Review 4.  Please stand by: how oncolytic viruses impact bystander cells.

Authors:  Leslee Sprague; Lynne Braidwood; Joe Conner; Kevin A Cassady; Fabian Benencia; Timothy P Cripe
Journal:  Future Virol       Date:  2018-08-08       Impact factor: 1.831

5.  Glycyrrhizin attenuates HMGB1-induced hepatocyte apoptosis by inhibiting the p38-dependent mitochondrial pathway.

Authors:  Geum-Youn Gwak; Tae Gun Moon; Dong Ho Lee; Byung Chul Yoo
Journal:  World J Gastroenterol       Date:  2012-02-21       Impact factor: 5.742

6.  Alterations in oxidant/antioxidant balance, high-mobility group box 1 protein and acute phase response in cross-bred suckling piglets suffering from rotaviral enteritis.

Authors:  Ujjwal Kumar De; Reena Mukherjee; Sukdeb Nandi; Bhimnere Hanumatnagouda Manjunatha Patel; Umesh Dimri; Chintu Ravishankar; Ashok Kumar Verma
Journal:  Trop Anim Health Prod       Date:  2014-05-22       Impact factor: 1.559

Review 7.  Targeting HMGB1 in the treatment of sepsis.

Authors:  Haichao Wang; Mary F Ward; Andrew E Sama
Journal:  Expert Opin Ther Targets       Date:  2014-01-06       Impact factor: 6.902

Review 8.  Molecular mechanism and therapeutic modulation of high mobility group box 1 release and action: an updated review.

Authors:  Ben Lu; Ce Wang; Mao Wang; Wei Li; Fangping Chen; Kevin J Tracey; Haichao Wang
Journal:  Expert Rev Clin Immunol       Date:  2014-04-19       Impact factor: 4.473

9.  Feline immunodeficiency virus OrfA alters gene expression of splicing factors and proteasome-ubiquitination proteins.

Authors:  Magnus Sundstrom; Udayan Chatterji; Lana Schaffer; Sohela de Rozières; John H Elder
Journal:  Virology       Date:  2007-10-25       Impact factor: 3.616

10.  Using Complementary and Alternative Medicines to Target the Host Response during Severe Influenza.

Authors:  Lisa M Alleva; Charles Cai; Ian A Clark
Journal:  Evid Based Complement Alternat Med       Date:  2009-09-24       Impact factor: 2.629
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.